Endovascular Treatment of Anterior Circulation Aneurysms With the p64 Flow Modulation Device: Mid- and Long-Term Results in 617 Aneurysms From a Single Center. Issue 4 (19th January 2021)

• Record Type: Journal Article
• Authors: Aguilar Pérez, Marta; Henkes, Elina; Hellstern, Victoria; Serna Candel, Carmen; Wendl, Christina; Bäzner, Hansjörg; Ganslandt, Oliver; Henkes, Hans
• Is Part Of: Operative neurosurgery. Volume 20:Issue 4(2021)
• Page Start: 355
• Page End: 363
• Publication Date: 2021-01-19
• Subjects: Intracranial aneurysms -- Flow diversion -- Flow diverter stent -- p64 Flow Modulation Device -- Anterior circulation aneurysm -- Endovascular treatment; Nervous system -- Surgery -- Periodicals; 617.480590
• DOI: 10.1093/ons/opaa425
• Languages: English
• ISSNs: 2332-4252

Abstract

Abstract: BACKGROUND: Flow diverters have become an important tool in the treatment of intracranial aneurysms, especially when dealing with difficult-to-treat or complex aneurysms. The p64 is the only fully resheathable and mechanically detachable flow diverter available for clinical use. OBJECTIVE: To evaluate the safety and effectiveness of p64 for the treatment of intracranial saccular unruptured aneurysms arising from the anterior circulation over a long-term follow-up period. METHODS: We retrospectively reviewed our prospectively maintained database to identify all patients who underwent treatment for an intracranial saccular (unruptured or beyond the acute hemorrhage phase) aneurysm arising from the anterior circulation with ≥1 p64 between December 2011 and December 2019. Fusiform aneurysms and dissections were excluded. Aneurysms with prior or concomitant saccular treatment (eg, coiling and clipping) were included. Aneurysms with parent vessel implants other than p64 were excluded. Anatomic features, intraprocedural complications, clinical outcome, as well as clinical and angiographic follow-ups were all recorded. RESULTS: In total, 530 patients (388 females; median age 55.9 yr) with 617 intracranial aneurysms met the inclusion criteria. The average number of devices used per aneurysm was 1.1 (range 1-3). Mean aneurysm dome size was 4.8 mm (range 1-27 mm). Treatment-related morbimortality was 2.4%. Early, mid-term, and long-term angiographic follow-up showed complete or near-complete aneurysm occlusion in 76.8%, 89.7%, and 94.5%, respectively. CONCLUSION: Treatment of intracranial saccular unruptured aneurysms of the anterior circulation using p64 is a safe and effective treatment option with high rate of occlusion at long-term follow-up and low morbimortality. Graphical Abstract: